
Keywords: ANDA; Abbreviated New Drug Application; API; Active Pharmaceutical Ingredient; BA; Bioavailability; BE; Bioequivalence; BCS; Biopharmaceutics Classification System; CES; Clinical Endpoint Studies; CRS; Confocal Raman Spectroscopy; DMK; Dermatopharmacokine